MetaVia grants Sarah Kaplan Browne 53,000 stock units

Half of the award is scheduled to vest on each of the first two grant anniversaries, contingent on continued service.

Rhea-AI Filing Summary

MetaVia Inc. Chief Medical Officer Sarah Kaplan Browne received a grant of 53,000 restricted stock units on October 12, 2026. Her reported position following the transaction was 53,000 shares. The units vest 50% on each of the first and second anniversaries of the grant date, subject to her continuing service on each applicable vesting date.

Insider Trade Summary

Grant/Award: 53,000 shares

Grant/Award 1 txn

Insider Browne Sarah Kaplan

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	53,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 53,000 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's Amended and Restated 2022 Equity Incentive Plan, which vests as to 50% on each of the first and second anniversaries of the date of grant, subject to the Reporting Person's continuing service on the applicable vesting date.

Key Figures

Restricted stock units granted: 53,000 restricted stock units Reported position following transaction: 53,000 shares First-anniversary vesting: 50% +1 more

4 metrics

Restricted stock units granted 53,000 restricted stock units Grant to Chief Medical Officer Sarah Kaplan Browne on October 12, 2026

Reported position following transaction 53,000 shares After the October 12, 2026 transaction

First-anniversary vesting 50% Of the restricted stock units, subject to continuing service

Second-anniversary vesting 50% Of the restricted stock units, subject to continuing service

Key Terms

restricted stock units, Amended and Restated 2022 Equity Incentive Plan, vesting

3 terms

restricted stock units financial

"grant of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Amended and Restated 2022 Equity Incentive Plan financial

"under the Issuer's Amended and Restated 2022 Equity Incentive Plan"

vesting financial

"on each of the first and second anniversaries"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many restricted stock units did MetaVia (MTVA) Chief Medical Officer Sarah Kaplan Browne receive?

Sarah Kaplan Browne received 53,000 restricted stock units on October 12, 2026. Her reported position following the transaction was 53,000 shares.

When do Sarah Kaplan Browne’s MetaVia (MTVA) restricted stock units vest?

The units vest 50% on each of the first and second anniversaries of the grant date, subject to her continuing service on each applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 04:06 PM EDT Accepted by SEC EDGAR 10/13/2026 - 04:06 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Browne Sarah Kaplan

(Last) (First) (Middle)

C/O METAVIA INC.

545 CONCORD AVENUE, SUITE 210

(Street)

CAMBRIDGE MASSACHUSETTS 02138

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MetaVia Inc. [ MTVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/12/2026		A		53,000(1)	A	$0	53,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's Amended and Restated 2022 Equity Incentive Plan, which vests as to 50% on each of the first and second anniversaries of the date of grant, subject to the Reporting Person's continuing service on the applicable vesting date.

	/s/ Phillip Torrence, by Power of Attorney	10/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)